Bioavailability of transgenic microRNAs in genetically modified plants

Background Transgenic expression of small RNAs is a prevalent approach in agrobiotechnology for the global enhancement of plant foods. Meanwhile, emerging studies have, on the one hand, emphasized the potential of transgenic microRNAs (miRNAs) as novel dietary therapeutics and, on the other, suggested potential food safety issues if harmful miRNAs are absorbed and bioactive. For these reasons, it is necessary to evaluate the bioavailability of transgenic miRNAs in genetically modified crops. Results As a pilot study, two transgenic Arabidopsis lines ectopically expressing unique miRNAs were compared and contrasted with the plant bioavailable small RNA MIR2911 for digestive stability and serum bioavailability. The expression levels of these transgenic miRNAs in Arabidopsis were found to be comparable to that of MIR2911 in fresh tissues. Assays of digestive stability in vitro and in vivo suggested the transgenic miRNAs and MIR2911 had comparable resistance to degradation. Healthy mice consuming diets rich in Arabidopsis lines expressing these miRNAs displayed MIR2911 in the bloodstream but no detectable levels of the transgenic miRNAs. Conclusions These preliminary results imply digestive stability and high expression levels of miRNAs in plants do not readily equate to bioavailability. This initial work suggests novel engineering strategies be employed to enhance miRNA bioavailability when attempting to use transgenic foods as a delivery platform. Electronic supplementary material The online version of this article (doi:10.1186/s12263-017-0563-5) contains supplementary material, which is available to authorized users.


Background
Since 1996, genetically modified (GM) crops have been commonly consumed by the general public [1]. Excitement has also been generated that some of these GM plants can help alleviate diseases and malnutrition [2,3]. The current safety assessments for these commercial crops predominately focus on the transgenic protein(s) [4,5]. However, agrobiotechnology often expresses novel RNA molecules in crops. Both the safety and therapeutic potential of transgenic RNAs in GM crops should be thoughtfully addressed [6].
Both microRNAs (miRNAs) and small interfering RNAs (siRNAs) are classes of small RNAs (sRNAs) that regulate gene expression [7]. RNA interference (RNAi) is an umbrella term that defines conditions where a sRNA directs sequence-specific gene repression. The prevailing view is that dietary sRNAs are not absorbed by consumers [8][9][10][11][12][13]; however, recent studies suggest that consumers may absorb and circulate dietary RNAs [14][15][16][17][18][19]. The uptake of GM diet-derived RNAs in controlled animal feeding studies should be carefully examined in order to establish guidelines for risk assessment and therapeutic applications.
Bioavailability is defined as the portion of a substance that reaches systemic circulation, and the bioavailability of dietary sRNAs appears to be low [13,20,21]. However, sRNAs ingested from plant-based foods may act as potent bioactives and have been implicated in reversing specific diseases in several cases [15-18, 20, 22, 23]. Meanwhile, numerous groups have found that dietary sRNAs are not bioavailable in animals [8,9,13]. The ability/inability to detect these dietary sRNAs in consumers has been attributed to a variety of potential differences among research groups, including methodology inconsistencies, contamination, and detection sensitivity issues [20,[24][25][26]. To date, research labs that have successfully demonstrated serum uptake of plant-based sRNAs have not addressed bioavailability of transgenic miRNAs in plant-based diets. One of the concerns of GM crops is the introduction of foreign genes into crops and its unpredictable consequences. For example, it is theoretically possible that transgenic miRNAs possess unique chemical modifications which allow them to be more bioavailable than a native miRNA. As a result, the characterization of the bioavailability of transgenic foreign miRNAs is warranted.
Our group has successfully demonstrated that the plant-based sRNA MIR2911, found in a melody of vegetables, is more stable during digestion and is bioavailable to mice fed vegetable-based diets [14,21,27,28]. Here we report the characterization of the digestive stability and dietary uptake of two miRNAs that are expressed in transgenic plants at levels comparable to the MIR2911 in fresh tissues. This small sampling of Arabidopsis lines suggests that transgenic miRNAs may not be readily bioavailable.

Generation of transgenic plant lines
The transgenic Arabidopsis line expressing the artificial miRNA termed amiR-RICE sequence (5′-UUU GGA AGC AAA GAA GCG GUG -3′) was obtained from Dr. Xiuren Zhang personal communication 2015). The binary construct for overexpression of a murine miRNA mmu-miR146a (5′-UGA GAA CUG AAU UCC AUG GGU U -3′) in Arabidopsis was made using the Gateway system (Invitrogen, Carlsbad, CA). The destination vector pBA-DC [29] and template entry vector pENTR-amiR-CPC3-159a [29] were provided by Dr. Xiuren Zhang, and mmu-miR146a was cloned into the entry vector as previously described [29]. The sequences of the cloning primers which contained the incorporated mmu-miR146a sequences were as follows: forward-5′-AAG ATA GAT CTT GAT CTG ACG ATG GAA GAA CCT GTG AAA TTC AGT TCT TGC ATG AGT TGA GCA GGG TA -3′; reverse-5′-AAG ACC CGG GAT GAA CCC ATG GAA TTC AGT TCT CAG AAG AGT AAA AGC CAT TA -3′ (mmu-miR146a business and passenger strand sequences are underlined). The growth conditions of Arabidopsis line were as described [30]. Transgenic lines were distinguished from untransformed by BASTA selection. Homozygous lines harboring the transgenic mmu-miR146a constructs were selected by segregation analysis in the T3 generation. The lines were analyzed by qRT-PCR for mmu-miR146a expression, and the lines displaying the most robust shoot expression in adult plants grown on soil for 45 days (stage 6.50, https://www.arabidopsis.org/portals/education/ growth.jsp) were used for diet preparation. From here on, the transgenic Arabidopsis lines used for mouse feeding studies and overexpressing amiR-RICE and mmu-miR146a are referred to as tg-RICE and tg-146, respectively.

Plant diet preparation
The shoot tissues from approximately 45-day-old tg-RICE or tg-146 plants were harvested and freeze dried to 30% of fresh weight, and the dried tissues was then finely ground and mixed with finely ground chow (Teklad 2914, Envigo, UK) and water at 1:2:2 weight ratios, according to procedures described previously [14] and stored at −20°C until use.

Degradation of miRNAs in transgenic plant diets
After preparation, the diets were incubated at room temperature. A 10-20-mg fraction of diet was removed at 1, 4, and 24 h to assay the stability of miRNAs within the diet [31]. To isolate total RNA from the plant diet, the miRNEASY RNA isolation kit (Qiagen, Valencia, CA) was used according to the manufacturer's instructions. Fifty femtomoles of an artificial miRNA termed C7 was used as an exogenous spike-in control.

Animal feeding studies
The experimental protocol involving mice was approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. Specifically, the institutional animal protocols AN-2624, AN-6438, and AN-6454 cover the experiments performed in this study. All mice were obtained from the Center for Comparative Medicine at Baylor College of Medicine. Male ICR mice at 8 to 10 weeks old were used in all feeding studies, which were replicated at least three times; the results shown are representative of the biological replicates. Mice were fed with the plant diets for 3 days before they were sacrificed. Each day, 5 g of the plant diet that contained 1 g of dried plant material was fed to each mouse. The daily intake of plant material per mouse is equivalent to 3.3 g of fresh plant tissue.

Serum collection and RNA extraction
Blood was collected via cardiac puncture as previously described [14]. Sera were separated at room temperature followed by centrifugation to remove all blood cells and debris. Total RNA was extracted from 100 μL of sera using the miRNEASY Kit following the manufacturer's recommendations.

Analysis of miRNA levels by qRT-PCR
TaqMan miRNA Assays for let-7dgi [32], C7, amiR-RICE, mmu-miR146a, MIR2911, and MIR168a were obtained from Life Technologies (Carlsbad, CA). Total RNA isolated was used in each reverse transcription (RT) reaction, as previously described [14]. To quantify miRNA levels in Arabidopsis, plant shoot material was ground to a fine powder in liquid nitrogen and then 10-20 mg was subjected to RNA isolation using the miRNeasy kit; 50 fmol of synthetic C7 was spiked into the plant Qiazol lysate as an exogenous RNA control. qRT-PCR was performed using a Biorad CFX96 Real-Time PCR Detection System, and data were analyzed using Biorad CFX software. Delta-Delta-Ct method was used to calculate the relative levels of miRNAs. Absolute concentrations of miRNAs were calculated based on standard curves obtained from serial dilutions of synthetic miRNAs [14] (Additional file 1: Figure S1).

In vitro digestion of miRNAs with porcine enzymes
In vitro digestion conditions were as previously described [33,34]. Briefly, the gastric phase was composed of a gastric electrolyte solution (7. and 1 N NaOH to adjust the pH to 7.0. One-milliliter PBS solution containing 10 pmol each of MIR2911, C7, amiR-RICE, and mmu-miR146a synthetic miRNAs was first mixed with 1-mL gastric phase and digested with slow rotation at 37°C for 60 min. The digestion mixture was then mixed with intestinal phase and digested with slow rotation at 37°C for an additional 75 min. One hundred microliters of samples were removed at 30 min, 60 min of the gastric phase, and 5, 30, and 75 min of the intestinal phase for analysis of the levels of surviving miRNAs. One hundred microliters of pre-digestion samples were used as controls for calculating the percentage of surviving miRNAs. MIR161 was used as an exogenous spike-in control. In vivo digestion of gavaged miRNAs ICR mice were fed purified diet (AIN-76a) for 7 days and then gavage-fed 400 pmol of MIR2911, C7, amiR-RICE, and mmu-miR146a. miRNA levels from the intestine were assessed 1 h post-gavage from the intestinal contents by flushing the excised intestines with 1 mL of PBS. One hundred microliters of the homogenized intestinal content was subject to RNA isolation and qRT-PCR analysis. MIR161 was used as an exogenous spike-in control.
Assaying miRNA levels from diets in the small intestines Mice fed transgenic diets and chow were used for this assay. The levels of miRNAs from the small intestine were determined using the intestinal contents collected by flushing the excised small intestines with 1 mL of PBS solution. One hundred microliters of the homogenized intestinal contents were analyzed by qRT-PCR for the levels of miRNAs.

Statistical analysis
Statistical analyses were performed with the Student t test formula in Microsoft Excel. Significance was set at p < 0.05. Data were presented as means ± SEMs.

Levels of transgenic miRNAs in plants
Arabidopsis was used for creating transgenic foods as it is a well-characterized model system [35]. Arabidopsis lines were engineered that express two miRNAs, amiR-RICE and mmu-miR146a. amiR-RICE is an artificial miRNA whose sequence has no homology to either plant or animal endogenous miRNAs, while mmu-miR146a's sequence is identical to the endogenous murine miRNA [36]. The expression level of amiR-RICE lines has been characterized (Xiuren Zhang; personal communication 2015). For mmu-miR146a, plant lines that showed the most robust expression were used for further studies (Additional file 2: Figure S2). qRT-PCR quantification results demonstrated that the expression levels of amiR-RICE and mmu-miR146a reached levels of 22.9 and 26.3 fmol/g of fresh weight, respectively, which is similar to the levels of MIR2911 in fresh shoot tissues (approximately 18-19 fmol/g) (Fig. 1).

Levels of transgenic miRNAs in diets
Our previous studies demonstrate that dietary abundance of miRNAs can change during diet degradation and impact uptake in consumers [31]. Levels of amiR-RICE and mmu-miR146a were assayed to determine their stability relative to that of MIR2911, in the diets that were incubated at room temperature. The abundance of amiR-RICE and mmu-miR146a decreased gradually over time by approximately 10-fold, to approximately 1 fmol/g of diet, while MIR2911's abundance, as we have demonstrated previously [31], was amplified by more than 85-fold after 24 h in the chow (Fig. 2).

Digestive stability of transgenic miRNAs
One of the main factors affecting bioavailability is the digestive stability of the nutrients [33]. Synthetic forms of the plant-based transgenic miRNAs, amiR-RICE and mmu-miR146a, were tested for their digestive stability using both an in vitro and in vivo assay. This was performed in comparison to MIR2911 and C7, which have been shown to have vastly different digestive stability in an in vitro assay, with MIR2911 being 10-fold more stable than C7 [27]. The in vitro digestion assay contained porcine digestion enzymes and demonstrated that amiR-RICE had similar digestive stability compared to MIR2911, while mmu-miR146a was significantly less stable than MIR2911, with surviving percentage in the intestinal phase after 75 min for mmu-miR146a being 0.39% comparing to 1.11% for MIR2911 (Fig. 3a). In the in vivo assay, gavage-fed synthetic miRNAs demonstrated much higher sensitivity to the murine digestive enzymes in vivo compared to the in vitro porcine system. After an hour, amiR-RICE had an approximately threefold higher survival percentage after gavage feeding compared to MIR2911 in the small intestines (0.0014% for amiR-RICE compared to 0.00045% for MIR2911) (Fig. 3b). Due to high background detection of endogenous mmu-miR146a in the murine intestines, the in vivo stability of mmu-miR146a was not analyzed (data not shown).

Bioavailability of transgenic miRNAs
When testing the bioavailability of the transgenic miRNAs using mice fed the plant diets, we concurrently analyzed the uptake of dietary miRNAs in circulation and the miRNA levels in the gut. The analysis of the gut content of the mice fed the transgenic plant diets revealed a difference in the surviving levels in the small intestines between MIR2911 and amiR-RICE or mmu-miR146a. On average, MIR2911 had a total abundance of about 238 fmol per mouse, while amiR-RICE only had about 2.7 fmol per mouse. mmu-miR146a was at a much higher level at around 38 fmol per mouse than amiR-RICE. However, a similar level was also detected in the chow-fed mice when they did not consume the transgenic plant material, suggesting that this mmu-miR146a was not derived from the diet (Fig. 4). In vitro and in vivo digestion assays demonstrated that amiR-RICE is at least as stable as MIR2911 (Fig. 3). However, when we analyzed sera from mice gavage fed 400 pmol of synthetic amiR-RICE, these miRNAs were not readily bioavailable (Fig. 5a). Mice fed diets supplemented with transgenic plant materials for 3 days also had negligible serum levels of the transgenic miRNAs. Furthermore, attempts to detect other plant miRNAs that have been reported by others to be bioavailable, albeit from other plant-based diets, were not successful (Additional file 3: Figure S3), However, the levels of MIR2911 in mice fed the plant diets (28.5 fM, or 1.3 × 10 7 copies per mouse) were more than fivefold higher than animals receiving the chow-based diet (5.2 fM, or 2.3 × 10 6 copies per mouse) (Fig. 5b). The enhanced levels of MIR2911 in the transgenic diet-fed mice served as a positive control for consumption of the diets and detection of plant-based RNAs in the mouse sera.

Discussion
Disagreements are common but crucial in science; the nascent field of dietary sRNAs is certainly no stranger to these controversies [20]. Transgenic crops can express populations of miRNAs not found in nature, and in view of the conflicting reports inferring bioavailability of diet-derived miRNAs, the disagreements among scientists are profound because they impact the way agencies and agrobiotechnology regulate and use this technology.
The two plant-derived transgenic miRNAs tested here demonstrated modest digestive stability (Fig. 3) and were abundant in the transgenic plants (Fig. 1); however, they were not readily bioavailable when fed to healthy mice (Fig. 5). Our group has also been unable to reliably detect (<32 Ct) canonical plant-based miRNAs in the sera of mice consuming plant-based diets (Additional file 3: Figure S3; (28)). Future analysis should be performed with mice fed with the transgenic plants for longer intervals and detection measured in the intestine as well as in organs outside the gastro-intestinal tract.
A variety of plant-based miRNAs can be found within the plant cellular matrix and may be coupled with other plant molecules such as proteins and polysaccharides [33]. These alterations may provide a conduit for dietary plant-derived miRNA uptake [33]. Using in vitro experiments, miR168a in soybean and mir166 in rice demonstrate more resistance to degradation than miR168a from rice and mir166 from soybean [33]. There are no sequence differences between these miRNAs; thus, it has been proposed that plant-specific mechanisms afford varying levels of protection from degradation. If this is true, bioavailability tests in transgenic Arabidopsis lines may not equate to bioavailability in other transgenic plants. Plant-specific exosome-like nanoparticles (EPDENs) may also mediate interspecies communication [37], but it remains an open question if these effects are mediated by miRNAs. In milk, specific miRNAs appear to be encapsulated in exosomes conferring protection against degradation and facilitating uptake [18,19]. These mechanisms may facilitate bioavailability of selected plant-based miRNAs, but with the two miRNAs tested here, they did not provide a conduit for absorption of the specific transgenic miRNAs tested here.
While these two transgenic miRNAs do not appear to be bioavailable in healthy mice, disease and nutritional status are important influences controlling consumer nutrient absorption [38]. A confluence of diet and health issues converges to influence uptake of plant-based genetic material [14,21,28]. Pharmacological regimes also facilitate the detection of gavage-fed miRNAs. Future work will focus on assaying bioavailability of GMderived miRNAs under these more permissive conditions.
Preparation methods could enhance the bioavailability of sRNAs in plant-based diets [16,23]. For traditional nutrients, various strategies, including thermal processing, soaking, and fermentation, aim to increase the physicochemical accessibility of the nutrients while decreasing the content of antinutrients [39]. Future work will need to be directed at how food processing and preparation practices impact the dietary sRNA quality of plant-based foods.
MIR2911 has several features that facilitate its bioavailability that do not appear to be characteristics of the miRNAs tested here: first, the GC-rich MIR2911 has a high digestive stability [16,27]; secondly, a protein complex protects MIR2911 [27]; third, synthesis via rRNA degradation dramatically increases MIR2911 abundance post-harvest [31]. The difference in intestinal levels of MIR2911 and the transgenic miRNAs could be explained by the degradation of the ribosomal RNAs that generate increased levels of MIR2911 [31]. In order for transgenic miRNAs to become more bioavailable, strategies need to be deployed that co-opt some or all of these tactics. It is interesting that one of the two transgenic miRNAs tested, amiR-RICE, was found to have similar digestive stability to MIR2911 in the in vitro system, or when gavage fed to the mice, but was not bioavailable. We posit this could be caused by either selective transport by the gut or differential stability or metabolism within the cells or in circulation.
Low bioavailability of the plant-based miRNAs does not negate potential bioactivity. Curcumin, a plant-based product, exhibits poor systemic bioavailability but still has potent pharmacological effects [40]. Like curcumin, emerging studies demonstrate that femtomolar amounts of a specific miRNA altered the fate of a targeted cell [41]. The miRNAs released by cancer cells can act as hormones [42,43]. Additionally, evidence suggests that plant sRNAs have therapeutic effects that are sequence independent [44], allowing speculation that it is the additive abundance of trace amounts of a variety of different plant-based sRNAs that confer biological activity. Low amounts of miRNAs may have biological functions that could revolutionize our concepts of plantbased bioactives.

Conclusions
Studies continue to suggest cross-kingdom gene regulation by dietary miRNAs; meanwhile, the majority of work has questioned the validity of these reports [20,24,45,46]. This pilot study suggests that the two transgenic miRNAs tested are not readily bioavailable to healthy consumers and therapeutic plant-based dietary miRNAs may need to focus on establishing conditions that allow miRNAs to overcome the obstacles hindering bioavailability.